Trademark Overview
On Friday, March 1, 2024, a trademark application was filed for JOHN THEURER CANCER CENTER with the United States Patent and Trademark Office. The USPTO has given the JOHN THEURER CANCER CENTER trademark a serial number of 98428934. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 30, 2024. This trademark is owned by Hackensack Meridian Health, Inc.. The JOHN THEURER CANCER CENTER trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Educational services, namely, providing classes, seminars and information in the fields of cancer, cancer care, bladder cancer, blood and marrow stem cell transplantation, bone tumors and sarcoma, brain and spine cancers, breast cancer, cancer rehabilitation, CAR-T Cell therapy, cardio-oncology, cervical cancer, children's cancer, colorectal cancer, endocrine and thyroid cancer, esophageal cancer, gastric cancer, gynecologic cancer, head and neck cancer, hepatobiliary and pancreatic cancer, kidney cancer, leukemia, lung cancer, multiple myeloma, noncancerous blood disorders, nutritional counseling and services, precision medicine, prostate cancer, skin cancer, radiation oncology, skin cancer, testis cancer and ureter cancer.
Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support
Hospital services, medical services, clinical mental health counseling and medical counseling in the fields of cancer, cancer care, bladder cancer, blood and marrow stem cell transplantation, bone tumors and sarcoma, brain and spine cancers, breast cancer, cancer rehabilitation, CAR-T Cell therapy, cardio-oncology, cervical cancer, children's cancer, colorectal cancer, endocrine and thyroid cancer, esophageal cancer, gastric cancer, gynecologic cancer, head and neck cancer, hepatobiliary and pancreatic cancer, kidney cancer, leukemia, lung cancer, multiple myeloma, noncancerous blood disorders, nutritional counseling and services, precision medicine, prostate cancer, skin cancer, radiation oncology, skin cancer, testis cancer and ureter cancer.
Medical testing and research services, namely, conducting clinical trials and surveillance studies of pharmaceuticals and medical devices for the health care industry
